Mukka Proteins will conduct a virtual one-on-one meeting with ADD Capital on September 17, 2026. The engagement is part of the company's ongoing dialogue with institutional investors.

The company notified the National Stock Exchange of India Limited and BSE Limited of the scheduled interaction. This disclosure aligns with compliance requirements for investor communication.

Meeting Details

The session will take place via virtual mode. It is structured as a one-on-one discussion between the company representatives and the fund manager.

Regulatory Compliance

Mukka Proteins made this intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that no unpublished price-sensitive information will be shared during the meeting.

Investors can access the latest presentation on the company's website. Mehaboobsab Mahmadgous Chalyal, Company Secretary and Compliance Officer, signed the disclosure.

Mukka Proteins shareholders approved all 15 resolutions proposed at its 16th Annual General Meeting held on September 10, 2026. The virtual meeting saw near-unanimous backing for the reappointment of the entire board and management team, alongside approvals for increased borrowing limits and related party transactions.

The scrutinizer’s report confirmed that all resolutions passed with requisite majority. Promoter group participation was robust, casting votes on nearly all shares held across most resolutions.

Voting Results Overview

The e-voting process, conducted via Central Depository Services (India) Limited (CDSL), recorded high engagement from promoter shareholders while public shareholder participation remained relatively low in terms of outstanding shares polled.

Note: Votes polled vary slightly by resolution due to abstentions or invalid votes.

Key Resolutions Passed

The company secured approval for multiple special and ordinary resolutions critical to its operational flexibility and governance structure.

Board and Management Reappointments

Shareholders reappointed three independent directors: Karkala Shankar Balachandra Rao, Hamad Bava, and Narendra Surendra Kamath. All three will serve a second term of five consecutive years commencing from January 15, 2027, to January 14, 2032. None are liable to retire by rotation.

Executive leadership renewals included Managing Director and CEO Kalandan Mohammed Haris, CFO Kalandan Mohammed Althaf, and COO Kalandan Mohammad Arif. Their terms are set for five years, effective from January 20, 2027, to January 19, 2032. While Haris is not liable to retire by rotation, Althaf and Arif are liable to do so.

Additionally, Whole-Time Director Kalandan Mohammad Arif and Non-Executive Director Mrs. Umaiyya Banu were reappointed following retirement by rotation.

Related Party Transactions

The AGM approved material related party transactions with four entities: Atlantic Marine Products Private Limited, Progress Frozen and Fish Sterilization, Ullal Fish Meal and Oil Company, and Mangalore Fish Meal and Oil Company.

For Resolution 12 (Atlantic Marine Products) and Resolution 14 (Ullal Fish Meal), a significant number of promoter votes were declared invalid because related parties inadvertently cast votes on these ordinary resolutions where they had an interest. Despite this, the resolutions passed with overwhelming support from non-interested shareholders.

Meeting Participation

Fifty-nine members attended the virtual AGM, comprising five promoter group representatives and 54 public shareholders. The quorum was present from the start, allowing proceedings to commence promptly at 3:00 pm. Statutory Auditors Shah & Taparia and Secretarial Auditor Chethan Nayak & Associates were present to address queries regarding their reports.